Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Oct;43(10):2372-5.
doi: 10.1128/AAC.43.10.2372.

Killing activities of trovafloxacin alone and in combination with beta-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically achievable in cerebrospinal fluid

F Fitoussi  1 , C Doit, P Geslin, E Bingen
Affiliations

Killing activities of trovafloxacin alone and in combination with beta-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically achievable in cerebrospinal fluid

F Fitoussi et al. Antimicrob Agents Chemother. 1999 Oct.

Abstract

The killing activities of trovafloxacin alone and in combination with beta-lactam agents (extended-spectrum cephalosporins, meropenem), rifampin, or vancomycin were evaluated against 20 genotypically characterized Streptococcus pneumoniae isolates for which amoxicillin MICs were >/=4 microg/ml (cefotaxime MICs, >/=4 microg/ml for six strains) at concentrations clinically achievable in cerebrospinal fluid. At 6 h the mean killing activity of trovafloxacin alone (range, 2.6 to 2.9 log(10) CFU/ml) did not vary significantly according to the susceptibility of the strains to beta-lactam agents. The activities of trovafloxacin or vancomycin added to the beta-lactam agents and the combination trovafloxacin-vancomycin were additive or indifferent. Against the ceftriaxone-resistant isolates, the killing activity of the combination of a beta-lactam agent and trovafloxacin did not differ significantly from that of a beta-lactam agent and vancomycin.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. American Academy of Pediatrics, Committee on Infectious Diseases. Therapy for children with invasive pneumococcal infections. Pediatrics. 1997;99:289–299. - PubMed
    1. Arguedas-Mohs A, Vargas S L, Bradley J S, Loaiza C, Rivera R, Vincent J, Teng R, Walterspiel J N for Chile PID-CRC Network Physicians. Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C: American Society for Microbiology; 1997. Trovafloxacin CSF penetration and pharmacokinetics in children, abstr. A-105; p. 21.
    1. Bingen E, Lambert-Zechovsky N, Mariani-Kurdjian P, Doit C, Aujard Y, Fournerie F, Mathieu H. Bacterial count in cerebrospinal fluid of children with meningitis. Eur J Clin Microbiol Infect Dis. 1990;9:278–281. - PubMed
    1. Bradley J S, Connor J D. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactams antibiotics. Pediatr Infect Dis J. 1991;10:871–873. - PubMed
    1. Bradley J S, Scheld W M. The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: current antibiotic therapy in the 1990s. Clin Infect Dis. 1997;24(Suppl. 2):213–221. - PubMed

MeSH terms

LinkOut - more resources